Inovio Pharmaceuticals Inc (INO)

[Lakers_w]

South Africa INO-4802, “Yes. We are definitely considering doing our trial in the heart of the storm - South Africa, India, etc … We will keep you informed. Thanks as always.” 7/2/21

”our primary focus is getting this [4800] to trial initiated next month to enroll healthy men and non-pregnant women 18 years and older across several countries, concentrating on Latin America, Asia, in addition to expanding the trial to Africa. We will engage the FDA on a formal lifting of the partial clinical hold as a part of our long-term plans to pursue a BLA approval in the US once INO-4800 efficacy is demonstrated in the global INNOVATE Phase 3 trial.” JK 8/9/21